Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody.
Neuromyelitis optica spectrum disorders may be misdiagnosed as Wernicke's encephalopathy.
A cytoarchitecture-driven myelin model reveals area-specific signatures in human primary and secondary areas using ultra-high resolution in-vivo brain MRI.
Reducing suffering in experimental autoimmune encephalomyelitis (EAE).
Aquaporin 4 Expression and Tissue Susceptibility to Neuromyelitis Optica.
Large-scale production of human mesenchymal stem cells for clinical applications.
Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression.
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Perception of muscular effort in multiple sclerosis.
Episodic Mood Changes Preceding an Exacerbation of Multiple Sclerosis.
Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.
Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients.
Multiple Sclerosis between Genetics and Infections: Human Endogenous Retroviruses in Monocytes and Macrophages.
A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
Reproducibility of T2 * mapping in the human cerebral cortex in vivo at 7 tesla MRI.
Analysis of upper limb movement in Multiple Sclerosis subjects during common daily actions.
Demyelination preceding a diagnosis of central nervous system lymphoma.
Towards a Quantitative OCT Image Analysis.
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.
Investigating the role of the corpus callosum in regulating motor overflow in multiple sclerosis.
Cellular immune responses in multiple sclerosis patients treated with interferon-beta.
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Early predictors of multiple sclerosis after a typical clinically isolated syndrome.
Seropositive Neuromyelitis Optica: A Pediatric Case Report and 6-Year Follow-Up.
Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.
Pages
« first
‹ previous
…
461
462
463
464
465
466
467
468
469
…
next ›
last »